— Ticker · NYQ —
BAX · Baxter International Inc.
Healthcare · Medical Instruments & Supplies
BAX
$19.59
▲ +1.40%
7-day move
7-day move
day$19.34 → $19.6952-wk$15.73 → $32.04avg vol8.1M / 3Mcap$10.1B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 9.7 |
| P/E (trailing) | — |
| EPS (forward) | $2.02 |
| EPS (trailing) | $-1.91 |
| PEG | 36.68 |
| Dividend | 1.03% |
The Risk
| Beta | 0.64 |
| Short % float | 12.33% |
| Float | 514.0M |
| Shares out | 516.5M |
| Avg vol (3M) | 8.1M |
| 52w range | $15.73 → $32.04 |
The Analyst Tape
strong buybuyholdunderperformsell
$21.54
avg 12-mo target
+10.0%
vs. last · 12 analysts
At a Glance
$10.1B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryMedical Instruments & Supplies
market cap$10.1B
websitebaxter.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for BAX in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for BAX.
Indicators That Mention BAX
8 of our 639 catalog map to BAX
SP-1139
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-2967
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1253
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-1346
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3489
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3062
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3534
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3555
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 639 indicators against four horizons. By chance alone, ~128 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Healthcare · by market cap · 7-day move
— Voices on BAX —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning BAX. Opinion, not wire.
No recent commentary mentioning BAX in the last 7 days.
Analyst · previewYou're seeing the public read on BAX. Analyst unlocks every pundit call on BAX with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with BAX as the target + the API / MCP feed.Compare tiers →